We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pharma to prevent future development failures.
- Authors
Eisberg, Neil
- Abstract
The article reports that a consortium designed for the speedy development of new drugs and avoid failures late in drug has been formed. Enlight Biosciences was formed by Merck & Co., Pfizer, Eli Lilly, PureTech Ventures and Nobel laureates such as Robert Horvitz. The consortium plans to invest $39 million on technologies that would better identify drugs likely to succeed in human trials. Englight aims to focus on developing tools to predict human responses and techniques such as biomarkers and imaging.
- Subjects
UNITED States; CONSORTIA; DRUG development; ELI Lilly &; Co.; HORVITZ, H. Robert, 1947-; MERCK &; Co. Inc.; PFIZER Inc.; PURETECH Ventures LLC; PHARMACOLOGY
- Publication
Chemistry & Industry, 2008, Issue 14, p5
- ISSN
0009-3068
- Publication type
Article